Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne

S. Veraldi, G. L. Giovene, C. Guerriero, V. Bettoli

Research output: Contribution to journalArticlepeer-review

Abstract

Aim. The aim of the present study was to evaluate the efficacy and tolerability of an emulsion of 0.2% Myrtacine® and 4% vitamin PP, compared with a simple emollient cream, in the treatment of retinoid dermatitis in patients with mild-to-moderate acne. Methods. This was a prospective, multicenter, open-label, non-randomised, parallel-group study. Patients (age 12-49 years; skin phototype I-IV) with mild-to-moderate acne, who were treated with a topical retinoid for at least one month and had developed skin irritation were assigned to one of the two following treatments: 0.2% Myrtacine® and 4% vitamin PP (N.=116) or a simple emollient cream (N.=48). Both treatments were administered twice daily, 1-1.5 hours after the application of the topical retinoid. Study endpoints were improvement in signs and symptoms of retinoid dermatitis, global efficacy, reduction in acne severity, overall clinical outcome, patient satisfaction and tolerability. Results. At day 28, compared with the simple emollient cream, 0.2% Myrtacine® and 4% vitamin PP significantly decreased signs (erythema, dryness/scaling, oedema, and roughness) and symptoms (itching, stinging, burning sensation and discomfort) of retinoid dermatitis (P

Original languageEnglish
Pages (from-to)491-497
Number of pages7
JournalGiornale Italiano di Dermatologia e Venereologia
Volume147
Issue number5
Publication statusPublished - Oct 2012

Keywords

  • Acne vulgaris
  • Dermatitis
  • Myrtaceae
  • Retinoids
  • Vitamin PP

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Efficacy and tolerability of topical 0.2% Myrtacine® and 4% vitamin PP for prevention and treatment of retinoid dermatitis in patients with mild to moderate acne'. Together they form a unique fingerprint.

Cite this